首页> 外文期刊>Journal of Clinical Microbiology >Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis.
【24h】

Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis.

机译:从几乎致命的单核细胞埃希氏菌病患者中分离出一株新的查菲埃里希氏菌。

获取原文
           

摘要

Ehrlichia chaffeensis is the causative agent of human monocytic ehrlichiosis, a disease that ranges in severity from asymptomatic infection to death. Only one isolate of E. chaffeensis has been made, the Arkansas strain, upon which all characterizations of the agent of human monocytic ehrlichiosis have been based. We report the isolation and characterization of a new strain of E. chaffeensis, the 91HE17 strain, which was cultivated from a patient with a nearly fatal illness. The new isolate grows best in culture with careful control of pH. The two isolates are nearly identical as determined by light and electron microscopy and have significant antigenic identity in fluorescent-antibody and immunoblot assays using polyclonal antisera and the E. chaffeensis-specific monoclonal antibody 1A9. Isolate 91HE17 had 99.9% nucleotide sequence identity with the Arkansas strain in the 16S rRNA gene. Parts of the Escherichia coli GroE operon homologs had identical restriction enzyme digestion patterns, and a 425-bp region of the GroEL gene had at least 99.8% sequence identity between the E. chaffeensis Arkansas and 91HE17 strains. Isolate 91HE17 lacked an epitope identified in E. chaffeensis Arkansas by the monoclonal antibody 6A1. This new E. chaffeensis isolate is very similar to the Arkansas strain and provides the opportunity to substantiate the existence of diversity among ehrlichiae which infect humans. Specific factors which differ among strains may then be compared to assess their potential contributions toward cellular pathogenicity and ultimately toward the development of disease in humans.
机译:恰菲埃里希氏菌是人类单核细胞埃希氏菌病的病原体,这种疾病的严重程度从无症状感染到死亡。仅制备了一种恰菲埃希氏菌的分离株,即阿肯色菌株,人单核细胞埃希氏菌病病原体的所有特征均以此为基础。我们报告了大肠杆菌的新菌株91HE17菌株的分离和鉴定,该菌株是从患有致命疾病的患者中培养出来的。仔细控制pH,新分离株在培养中生长最佳。如通过光学和电子显微镜所确定的,这两个分离物几乎相同,并且在使用多克隆抗血清和恰菲埃里希氏体特异性单克隆抗体1A9的荧光抗体和免疫印迹测定中具有显着的抗原同一性。分离株91HE17与16S rRNA基因中的阿肯色菌株具有99.9%的核苷酸序列同一性。大肠杆菌GroE操纵子同源物的某些部分具有相同的限制性酶切消化模式,GroEL基因的425 bp区域在恰菲埃肯州阿肯色州菌株和91HE17菌株之间具有至少99.8%的序列同一性。分离株91HE17缺乏在阿肯色州大肠杆菌中通过单克隆抗体6A1鉴定的表位。该新的恰菲大肠杆菌分离株与阿肯色菌株非常相似,并提供了证实感染人类的​​大肠杆菌中多样性的存在的机会。然后可以比较菌株之间不同的特定因素,以评估其对细胞致病性以及最终对人类疾病发展的潜在贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号